MyChesCo on MSN1d
Johnson & Johnson Advances Ulcerative Colitis Treatment with FDA Filing for TREMFYA® Subcutaneous Regimen
SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...
WBAL TV Baltimore on MSN2d
Some women have to be vigilant for UC symptoms
The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...
Becker's ASC2d
New AGA guidance for ulcerative colitis treatment: 8 things to know
5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...
News Medical6d
More than 100,000 young people in the US live with inflammatory bowel disease
The prevalence of inflammatory bowel disease in U.S. children under 20 is increasing, with over 100,000 affected, revealing ...
Yahoo6d
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Johnson & Johnson (J&J) Innovation Medicine has submitted a request to the US Food and Drug Administration (FDA) to approve a ...
Science Daily6d
How nerve stimulation could ease inflammatory bowel disease
A new study shows stimulating the vagus nerve in mice with colitis reduced stress-driven symptoms of inflammatory bowel disease by regulating SUMOylation, an immune response that triggers gut ...